EGFR and non-small cell lung carcinoma: Similarly, a prolonged time to treatment failure (TTF) and central nervous system progression-free survival (CNS-PFS) for EGFR-mutant NSCLC patients with CNS metastases with upfront brain radiotherapy was found by Saida et al.